Alliance Pharma plc (APH) — Cash Flow-to-Debt Ratio
Alliance Pharma plc (APH) has a Cash Flow-to-Debt Ratio of 0.13x as of December 2024, meaning its operating cash flow of GBX20.47 Million could theoretically repay 0% of its total liabilities (GBX161.50 Million) in one year. Explore how much of Alliance Pharma plc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Alliance Pharma plc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Alliance Pharma plc across 28 annual periods. Also explore how large is Alliance Pharma plc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Alliance Pharma plc (1999–2024)
Year-by-year debt coverage analysis for Alliance Pharma plc. For market capitalisation and broader financial context, see Alliance Pharma plc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.24x | GBX38.72 Million | GBX161.50 Million | ▲ +50.4% |
| 2023 | 0.16x | GBX31.41 Million | GBX197.05 Million | ▲ +89.8% |
| 2022 | 0.08x | GBX20.97 Million | GBX249.75 Million | ▼ -52.0% |
| 2021 | 0.17x | GBX38.66 Million | GBX221.00 Million | ▼ -4.1% |
| 2020 | 0.18x | GBX41.57 Million | GBX227.90 Million | ▼ -31.9% |
| 2019 | 0.27x | GBX35.76 Million | GBX133.46 Million | ▲ +83.0% |
| 2018 | 0.15x | GBX22.17 Million | GBX151.41 Million | ▼ -26.7% |
| 2017 | 0.20x | GBX26.58 Million | GBX133.10 Million | ▲ +66.9% |
| 2016 | 0.12x | GBX16.93 Million | GBX141.47 Million | ▲ +94.6% |
| 2015 | 0.06x | GBX7.98 Million | GBX129.75 Million | ▼ -80.0% |
| 2014 | 0.31x | GBX11.42 Million | GBX37.09 Million | ▲ +30.0% |
| 2013 | 0.24x | GBX10.03 Million | GBX42.32 Million | ▼ -7.0% |
| 2012 | 0.25x | GBX12.44 Million | GBX48.78 Million | ▲ +11.6% |
| 2011 | 0.23x | GBX8.72 Million | GBX38.16 Million | ▼ -36.6% |
| 2010 | 0.36x | GBX14.89 Million | GBX41.32 Million | ▲ +88.2% |
| 2009 | 0.19x | GBX7.69 Million | GBX40.17 Million | ▲ +193.4% |
| 2008 | 0.07x | GBX2.62 Million | GBX40.07 Million | ▲ +52.4% |
| 2007 | 0.04x | GBX1.70 Million | GBX39.74 Million | ▲ +277.2% |
| 2006 | -0.02x | GBX-910.00K | GBX37.63 Million | ▼ -289.8% |
| 2005 | 0.01x | GBX360.00K | GBX28.26 Million | ▲ +238.3% |
| 2005 | -0.01x | GBX-253.00K | GBX27.47 Million | ▲ +81.1% |
| 2004 | -0.05x | GBX-1.18 Million | GBX24.21 Million | ▼ -204.9% |
| 2003 | 0.05x | GBX976.00K | GBX21.01 Million | ▲ +101.4% |
| 2002 | -3.33x | GBX-80.26K | GBX24.11K | ▼ -3886.0% |
| 2002 | -0.08x | GBX-692.00K | GBX8.29 Million | ▼ -1516.4% |
| 2001 | 0.01x | GBX20.00K | GBX3.39 Million | ▼ -93.2% |
| 2000 | 0.09x | GBX336.00K | GBX3.90 Million | ▼ -59.8% |
| 1999 | 0.21x | GBX1.38 Million | GBX6.45 Million | — |